Bangladesh vs Indonesia: Women's share of population ages 15+ living with HIV
Bangladesh
32.4%
in 2024
Indonesia
32.7%
in 2024
Bangladesh rank
98th
Indonesia rank
95th
Women's share of population ages 15+ living with HIV over time
- Bangladesh
- Indonesia
How they compare
Indonesia currently reports 32.7% against 32.4% in Bangladesh, a difference of 0.3%.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Bangladesh ahead.
Bangladesh ranks 98th and Indonesia ranks 95th of 172 countries.
Across the 4 decades both report, Bangladesh averaged higher in 2 and Indonesia in 2.
Head to head by decade
| Decade | Bangladesh | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 26.6% | 19.6% | 7.0% | Bangladesh |
| 2000s | 25.5% | 23.1% | 2.3% | Bangladesh |
| 2010s | 31.9% | 32.4% | 0.5% | Indonesia |
| 2020s | 32.7% | 33.3% | 0.6% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher women's share of population ages 15+ living with hiv, Bangladesh or Indonesia?
- Indonesia, at 32.7% against 32.4% in Bangladesh as of 2024.
- What is the difference in women's share of population ages 15+ living with hiv between Bangladesh and Indonesia?
- 0.3%, with Indonesia ahead.
- How many years of comparable data are there for Bangladesh and Indonesia?
- 35 years are reported by both, from 1990 to 2024.
- How do Bangladesh and Indonesia rank globally for women's share of population ages 15+ living with hiv?
- Bangladesh ranks 98th and Indonesia ranks 95th of 172 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Women's share of population ages 15+ living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of HIV is the percentage of people who are infected with HIV. Female rate is as a percentage of the total population ages 15+ who are living with HIV.